Brief: Genetic Signatures Says Decision To Cease Development Of US Respiratory Product
27/05/2024 02:31
May 27 (Reuters) - Genetic Signatures Ltd GSS.AX :
* DECISION TO CEASE DEVELOPMENT OF US RESPIRATORY PRODUCT
Source text for Eikon: ID:nASX1mZq6q
Further company coverage: GSS.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Genetic Signatures
See all newsBrief: Genetic Signatures Says Anne Lockwood To Conclude As Interim Managing Director
Brief: Genetic Signatures Logs Q3 Sales A$3 Mln
Australia's Genetic Signatures extends gain on deal with Danish hospital
Australia's Genetic Signatures jumps on supply agreement with Denmark hospital
Brief: Genetic Signatures Signs Danish Supply Agreement